Transseptal BATMAN for High-Risk Valve-in-Ring Procedures: A Case Series.

Valve-in-ring procedures represent a feasible solution for high-risk patients with surgical repair failure. The risk of left ventricular outflow tract obstruction increases the challenge, and transcatheter approaches to prevent it are technically demanding and often do not resolve it. We demonstrate the feasibility and safety of a transseptal balloon-assisted translocation of the anterior mitral leaflet for valve-in-ring implantation.
Competing Interests: Dr Denti has received speaker honoraria from Abbott and Edwards Lifesciences; and has served as a consultant for Pi-Cardia, InnovHeart HRV, and Approximate. Dr Maisano has received grants and personal fees from Abbott, Medtronic, Edwards Lifesciences, Biotronik, Boston Scientific, NVT, Terumo, Perifect, Xeltis, Transseptal solutions, Cardiovalve, Magenta, 4Tech, Coregard, SwissVortex, and Occlufit. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
(© 2024 The Authors.)